Colombia's adherence to international standards makes it a "big space" for pharma growth, says trade industry boss

Learning from the standards set by the USA, Europe and Brazil, Colombia is fast catching up in making the country an attractive place to research, seek approval for and market medicines, according to Yaneth Giha Tovar (pictured above), executive president of AFRIDO, the national trade association for the pharmaceutical industry.

Talking to Angel Galindo, The Pharma Letter’s Latin America correspondent, she said that while there have been a number of initiatives involving industry, academia and government, a lot more can still be done to ensure Colombia is a country where pharmaceutical innovation thrives.

Aiming for access and regulatory improvements